ESCITALOPRAM OXALATE

Escitalopram Oxalate Adverse Events Reported to the FDA Over Time

How are Escitalopram Oxalate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Escitalopram Oxalate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Escitalopram Oxalate is flagged as the suspect drug causing the adverse event.

Most Common Escitalopram Oxalate Adverse Events Reported to the FDA

What are the most common Escitalopram Oxalate adverse events reported to the FDA?

Completed Suicide	155 (1.84%)
Drug Interaction	133 (1.58%)
Suicide Attempt	111 (1.32%)
Tremor	93 (1.1%)
Overdose	92 (1.09%)
Fall	90 (1.07%)
Somnolence	87 (1.03%)
Depression	79 (.94%)
Anxiety	76 (.9%)
Fatigue	76 (.9%)
Serotonin Syndrome	76 (.9%)
	Show More
Hyponatraemia	74 (.88%)
Suicidal Ideation	74 (.88%)
Confusional State	73 (.87%)
Condition Aggravated	72 (.85%)
Dizziness	72 (.85%)
Intentional Overdose	72 (.85%)
Nausea	68 (.81%)
Multiple Drug Overdose Intentional	67 (.79%)
Convulsion	65 (.77%)
Cardiac Arrest	64 (.76%)
Malaise	64 (.76%)
Vomiting	62 (.74%)
Agitation	59 (.7%)
Loss Of Consciousness	58 (.69%)
Diarrhoea	56 (.66%)
Restlessness	56 (.66%)
Maternal Drugs Affecting Foetus	54 (.64%)
Tachycardia	54 (.64%)
Multiple Drug Overdose	50 (.59%)
Respiratory Arrest	50 (.59%)
Drug Ineffective	48 (.57%)
Headache	48 (.57%)
Hypotension	47 (.56%)
Insomnia	47 (.56%)
Drug Exposure During Pregnancy	42 (.5%)
Feeling Abnormal	42 (.5%)
Aggression	39 (.46%)
Dyskinesia	39 (.46%)
Dyspnoea	39 (.46%)
Weight Increased	39 (.46%)
Alanine Aminotransferase Increased	38 (.45%)
Asthenia	37 (.44%)
Weight Decreased	37 (.44%)
Delirium	31 (.37%)
Rhabdomyolysis	31 (.37%)
Coma	30 (.36%)
Electrocardiogram Qt Prolonged	30 (.36%)
Paraesthesia	30 (.36%)
Caesarean Section	29 (.34%)
Decreased Appetite	29 (.34%)
Abdominal Pain	28 (.33%)
Renal Failure	28 (.33%)
Urinary Tract Infection	28 (.33%)
Pyrexia	27 (.32%)
Blood Creatine Phosphokinase Increa...	26 (.31%)
Drug Toxicity	26 (.31%)
Hallucination, Visual	26 (.31%)
Syncope	26 (.31%)
Dehydration	25 (.3%)
General Physical Health Deteriorati...	25 (.3%)
Grand Mal Convulsion	25 (.3%)
Hyperhidrosis	25 (.3%)
Hypertension	25 (.3%)
Abnormal Dreams	24 (.28%)
Cough	24 (.28%)
Disorientation	24 (.28%)
Dysarthria	24 (.28%)
Neck Pain	24 (.28%)
Neuroleptic Malignant Syndrome	24 (.28%)
Pregnancy	24 (.28%)
Renal Failure Acute	24 (.28%)
Self-injurious Ideation	24 (.28%)
Blood Pressure Increased	23 (.27%)
Crying	23 (.27%)
Depressed Level Of Consciousness	23 (.27%)
Oedema Peripheral	23 (.27%)
Thrombocytopenia	23 (.27%)
Abnormal Behaviour	22 (.26%)
Aspartate Aminotransferase Increase...	22 (.26%)
Irritability	22 (.26%)
Sleep Disorder	22 (.26%)
Blood Sodium Decreased	21 (.25%)
Cardio-respiratory Arrest	21 (.25%)
Disturbance In Attention	21 (.25%)
Premature Baby	20 (.24%)
Balance Disorder	19 (.23%)
Hepatic Cirrhosis	19 (.23%)
Pneumonia	19 (.23%)
Vertigo	19 (.23%)
Amnesia	18 (.21%)
Atrial Fibrillation	18 (.21%)
Blood Alkaline Phosphatase Increase...	18 (.21%)
Disease Recurrence	18 (.21%)
Dystonia	18 (.21%)
Eczema	18 (.21%)
Hyperphagia	18 (.21%)
Lethargy	18 (.21%)
Muscle Rigidity	18 (.21%)
Off Label Use	18 (.21%)
Pulmonary Embolism	18 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Escitalopram Oxalate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Escitalopram Oxalate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Escitalopram Oxalate

What are the most common Escitalopram Oxalate adverse events reported to the FDA?

Neurological	598 (7.09%)
Suicidal And Self-injurious Behavio...	388 (4.6%)
Medication Errors	312 (3.7%)
Cardiac Arrhythmias	297 (3.52%)
Movement Disorders	252 (2.99%)
Therapeutic And Nontherapeutic Effe...	231 (2.74%)
Respiratory	228 (2.7%)
Gastrointestinal Signs	222 (2.63%)
Anxiety Disorders	218 (2.58%)
Chemical Injury And Poisoning	166 (1.97%)
Electrolyte And Fluid Balance Condi...	147 (1.74%)
	Show More
Injuries	146 (1.73%)
Sleep Disorders	138 (1.64%)
Deliria	130 (1.54%)
Depressed Mood Disorders	130 (1.54%)
Epidermal And Dermal Conditions	129 (1.53%)
Seizures	129 (1.53%)
Cardiac And Vascular Investigations	121 (1.43%)
Muscle	119 (1.41%)
Neuromuscular	116 (1.38%)
Hepatobiliary	111 (1.32%)
Hepatic And Hepatobiliary	110 (1.3%)
Hematology Investigations	106 (1.26%)
Physical Examination Topics	105 (1.24%)
Infections - Pathogen Unspecified	102 (1.21%)
Gastrointestinal Motility And Defec...	83 (.98%)
Disturbances In Thinking	81 (.96%)
Appetite And General Nutritional	78 (.92%)
Water, Electrolyte And Mineral	77 (.91%)
Mental Impairment	76 (.9%)
Personality Disorders	75 (.89%)
Renal Disorders	71 (.84%)
Decreased And Nonspecific Blood Pre...	70 (.83%)
Enzyme	69 (.82%)
Mood Disorders	69 (.82%)
Changes In Physical Activity	65 (.77%)
Central Nervous System Vascular	63 (.75%)
Gastrointestinal Hemorrhages	60 (.71%)
Vision	58 (.69%)
Urinary Tract Signs	55 (.65%)
Metabolic, Nutritional And Blood Ga...	54 (.64%)
Lifestyle Issues	52 (.62%)
Headaches	50 (.59%)
Musculoskeletal And Connective Tiss...	49 (.58%)
Psychiatric	46 (.55%)
Ocular Neuromuscular	42 (.5%)
Skin Appendage Conditions	42 (.5%)
Renal And Urinary Tract Investigati...	39 (.46%)
Psychiatric And Behavioural Symptom...	36 (.43%)
Obstetric And Gynecological Therape...	34 (.4%)
Anemias Nonhemolytic And Marrow Dep...	33 (.39%)
Body Temperature Conditions	33 (.39%)
Lower Respiratory Tract Disorders	33 (.39%)
White Blood Cell	33 (.39%)
Cardiac Disorder Signs	31 (.37%)
Vascular	30 (.36%)
Fatal Outcomes	29 (.34%)
Inner Ear And Viiith Cranial Nerve	29 (.34%)
Neurological, Special Senses And Ps...	29 (.34%)
Vascular Hypertensive	29 (.34%)
Platelet	28 (.33%)
Bone And Joint Injuries	27 (.32%)
Lipid Analyses	27 (.32%)
Upper Respiratory Tract Disorders	27 (.32%)
Cardiac And Vascular Disorders Cong...	26 (.31%)
Sexual Dysfunctions, Disturbances A...	26 (.31%)
Therapeutic Procedures And Supporti...	26 (.31%)
Neonatal And Perinatal Conditions	25 (.3%)
Pregnancy, Labour, Delivery And Pos...	25 (.3%)
Allergic Conditions	24 (.28%)
Myocardial	24 (.28%)
Acid-base	22 (.26%)
Protein And Chemistry Analyses	22 (.26%)
Toxicology And Therapeutic Drug Mon...	22 (.26%)
Pulmonary Vascular	21 (.25%)
Manic And Bipolar Mood Disorders	20 (.24%)
Schizophrenia And Other Psychotic	20 (.24%)
Coronary Artery	19 (.23%)
Heart Failures	19 (.23%)
Salivary Gland Conditions	19 (.23%)
Abortions And Stillbirth	18 (.21%)
Gastrointestinal Ulceration And Per...	18 (.21%)
Joint	18 (.21%)
Musculoskeletal And Connective Tiss...	18 (.21%)
Neurological Disorders Congenital	18 (.21%)
Breast	17 (.2%)
Vascular Hemorrhagic	17 (.2%)
Viral Infectious	17 (.2%)
Gastrointestinal Conditions	16 (.19%)
Bacterial Infectious	15 (.18%)
Gastrointestinal Inflammatory Condi...	15 (.18%)
Oral Soft Tissue Conditions	15 (.18%)
Arteriosclerosis, Stenosis, Vascula...	14 (.17%)
Sexual Function And Fertility	14 (.17%)
Sleep Disturbances	14 (.17%)
Cardiac Valve	13 (.15%)
Cranial Nerve Disorders	13 (.15%)
Endocrine Investigations	13 (.15%)
Glucose Metabolism Disorders	13 (.15%)
Ocular Infections, Irritations And ...	13 (.15%)
Thyroid Gland	13 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Escitalopram Oxalate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Escitalopram Oxalate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.